Literature DB >> 30382470

Reactive oxygen species-induced alterations in H19-Igf2 methylation patterns, seminal plasma metabolites, and semen quality.

Mahsa Darbandi1, Sara Darbandi1, Ashok Agarwal2, Saradha Baskaran2, Sulagna Dutta3, Pallav Sengupta4, Hamid Reza Khorram Khorshid5, Sandro Esteves6, Kambiz Gilany1, Mehdi Hedayati7, Fatemeh Nobakht8, Mohammad Mehdi Akhondi9, Niknam Lakpour1, Mohammad Reza Sadeghi10.   

Abstract

PURPOSE: This study was conducted in order to investigate the effects of reactive oxygen species (ROS) levels on the seminal plasma (SP) metabolite milieu and sperm dysfunction.
METHODS: Semen specimens of 151 normozoospermic men were analyzed for ROS by chemiluminescence and classified according to seminal ROS levels [in relative light units (RLU)/s/106 sperm]: group 1 (n = 39): low (ROS < 20), group 2 (n = 38): mild (20 ≤ ROS < 40), group 3 (n = 31): moderate (40 ≤ ROS < 60), and group 4 (n = 43): high (ROS ≥ 60). A comprehensive analysis of SP and semen parameters, including conventional semen characteristics, measurement of total antioxidant capacity (TAC), sperm DNA fragmentation index (DFI), chromatin maturation index (CMI), H19-Igf2 methylation status, and untargeted seminal metabolic profiling using nuclear magnetic resonance spectroscopy (1H-NMR), was carried out. RESULT(S): The methylation status of H19 and Igf2 was significantly different in specimens with high ROS (P < 0.005). Metabolic fingerprinting of these SP samples showed upregulation of trimethylamine N-oxide (P < 0.001) and downregulations of tryptophan (P < 0.05) and tyrosine/tyrosol (P < 0.01). High ROS significantly reduced total sperm motility (P < 0.05), sperm concentration (P < 0.001), and seminal TAC (P < 0.001) but increased CMI and DFI (P < 0.005). ROS levels have a positive correlation with Igf2 methylation (r = 0.19, P < 0.05), DFI (r = 0.40, P < 0.001), CMI (r = 0.39, P < 0.001), and trimethylamine N-oxide (r = 0.45, P < 0.05) and a negative correlation with H19 methylation (r = - 0.20, P < 0.05), tryptophan (r = - 0.45, P < 0.05), sperm motility (r = - 0.20, P < 0.05), sperm viability (r = - 0.23, P < 0.01), and sperm concentration (r = - 0.30, P < 0.001). CONCLUSION(S): Results showed significant correlation between ROS levels and H19-Igf2 gene methylation as well as semen parameters. These findings are critical to identify idiopathic male infertility and its management through assisted reproduction technology (ART).

Entities:  

Keywords:  Oxidative stress; Reactive oxygen species; Sperm DNA fragmentation; Sperm DNA methylation; Total antioxidant capacity

Mesh:

Substances:

Year:  2018        PMID: 30382470      PMCID: PMC6420547          DOI: 10.1007/s10815-018-1350-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  18 in total

1.  Profiling the DNA methylation patterns of imprinted genes in abnormal semen samples by next-generation bisulfite sequencing.

Authors:  Wanhong He; Υuhua Sun; Sufen Zhang; Xing Feng; Minjie Xu; Jianfeng Dai; Xiaohua Ni; Xin Wang; Qihan Wu
Journal:  J Assist Reprod Genet       Date:  2020-06-23       Impact factor: 3.412

2.  The effect of paternal age on semen quality and fertilization outcome in men with normal sperm DNA compaction, reactive oxygen species, and total antioxidant capacity levels.

Authors:  Sara Darbandi; Mahsa Darbandi; Hamid Reza Khorram Khorshid; Mohammad Reza Sadeghi; Mahnaz Heidari; Ghazaleh Cheshmi; Mohammad Mehdi Akhondi
Journal:  Turk J Urol       Date:  2019-02-05

Review 3.  Functional histology of human scrotal wall layers and their overlooked relation with infertility: a narrative review.

Authors:  Georges Raad; Vinal Massaad; Munevver Serdarogullari; Hassan W Bakos; Rita Issa; Maria Joy Khachan; Nay Makhlouf; Youmna Mourad; Chadi Fakih; Fadi Fakih
Journal:  Int J Impot Res       Date:  2022-04-29       Impact factor: 2.896

Review 4.  Oxidative Stress and Idiopathic Male Infertility.

Authors:  Pallav Sengupta; Shubhadeep Roychoudhury; Monika Nath; Sulagna Dutta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations.

Authors:  Sandro C Esteves; Armand Zini; Robert Matthew Coward; Donald P Evenson; Jaime Gosálvez; Sheena E M Lewis; Rakesh Sharma; Peter Humaidan
Journal:  Andrologia       Date:  2020-10-27       Impact factor: 2.775

6.  A Comparison Between Two Assays for Measuring Seminal Oxidative Stress and their Relationship with Sperm DNA Fragmentation and Semen Parameters.

Authors:  Sheryl T Homa; Anna M Vassiliou; Jesse Stone; Aideen P Killeen; Andrew Dawkins; Jingyi Xie; Farley Gould; Jonathan W A Ramsay
Journal:  Genes (Basel)       Date:  2019-03-19       Impact factor: 4.096

7.  Association of Sperm Methylation at LINE-1, Four Candidate Genes, and Nicotine/Alcohol Exposure With the Risk of Infertility.

Authors:  Wenjing Zhang; Min Li; Feng Sun; Xuting Xu; Zhaofeng Zhang; Junwei Liu; Xiaowei Sun; Aiping Zhang; Yupei Shen; Jianhua Xu; Maohua Miao; Bin Wu; Yao Yuan; Xianliang Huang; Huijuan Shi; Jing Du
Journal:  Front Genet       Date:  2019-10-18       Impact factor: 4.599

Review 8.  Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility.

Authors:  Rossella Cannarella; Rosita A Condorelli; Laura M Mongioì; Sandro La Vignera; Aldo E Calogero
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

9.  Efficacy of Antioxidant Supplementation on Conventional and Advanced Sperm Function Tests in Patients with Idiopathic Male Infertility.

Authors:  Mohamed Arafa; Ashok Agarwal; Ahmad Majzoub; Manesh Kumar Panner Selvam; Saradha Baskaran; Ralf Henkel; Haitham Elbardisi
Journal:  Antioxidants (Basel)       Date:  2020-03-06

Review 10.  Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.

Authors:  Li Yuan; Zhi-Yuan Xu; Shan-Ming Ruan; Shaowei Mo; Jiang-Jiang Qin; Xiang-Dong Cheng
Journal:  Mol Cancer       Date:  2020-05-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.